A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes

Summary

The primary objective of the study is to evaluate the safety of escalating multiple doses over 2 weeks of CAT 1004 compared to placebo in patients with Type 2 diabetes (T2D). Secondary objectives include evaluation of the pharmacokinetics (PK) and pharmacodynamics of escalating multiple doses of CAT-1004 in patients with T2D.

Timeline

Start

2011-12

Primary completion

2012-04

Completion

2012-04

Drugs

Indications